Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer

European Journal of Cancer Prevention

Volumn 12, Issue 4, 2003, Pages 321-326

  Palan, P R ^a   Mikhail, M S ^a   Shaban, D W ^a   Romney, S L ^b  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

tocopherol; Tocophero; Antioxidants; Cervical cancer; Cervical dysplasia; Coenzyme Q10

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GAMMA TOCOPHEROL; REACTIVE OXYGEN METABOLITE; TOCOPHEROL; UBIDECARENONE;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; ANTIOXIDANTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GAMMA-TOCOPHEROL; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; UBIQUINONE; UTERINE CERVICAL NEOPLASMS;

EID: 0042738869     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200308000-00013     Document Type: Article

References (42)

1. An HJ, Cho NH, Lee SY, et al. (2003). Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97:1672-1680.
2. Block G, Patterson B, Subar A (1993). Fruits, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18:1-29.
3. Bosch FX, Lorincz A, Munoz N, et al. (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
4. Butterworth CE Jr, Hatch KD, Macaluso M, et al. (1991). Folate deficiency and cervical dysplasia. JAMA 267:528-533.
5. Butterworth CE, Jr., Hatch KD, Soong SJ, et al. (1992). Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 166:803-809.
6. Chow CK (2001). Vitamin E regulation of mitochondrial superoxide generation. Biol Signals Recept 10:112-124.
7. Crane FL, Navas P (1997). The diversity of coenzyme Q function. Mol Aspects Med 18:s1-s8.
8. Devaraj S, Traber MG (2003). Gamma-tocopherol, the new vitamin E? Am J Clin Nutr 77:530-531.
9. de Vet HCW, Knipschild PG, Willebrand D, et al. (1991). The effect of β-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 44:272-283.
10. Dogan J, Schatzkini A (1991). Antioxidant micronutrients in cancer prevention. Nutr Cancer 15:43-68.
11. Ernster L, Dallner G (1995). Biochemical biophysical and medical aspects of ubiquinone function. Biochim Biophys Acta 1271:195-204.
12. 10. Biochem Biophys Res Commun 192:241-245.
13. 10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 234:296-299.
14. Frei B, Kim MC, Ames BN (1990). Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 87:4879-4883.
15. Goodman MT, Kiviat N, McDuffie K, et al. (1998). The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 7:537-544.
16. Ho GY, Palan PR, Basu J, et al. (1998). Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78:594-599.
17. 10: could it have a role in cancer management? Biofactors 9:365-370.
18. Ingold KU, Webb AC, Witter D, et al. (1987). Vitamin E remains the major ripid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys 259:224-225.
19. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN (2000). γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 97:11494-11499.
20. Jiang Q, Christen S, Shigenaga MK, Ames BN (2001). α-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74:714-722.
21. 10 concentrations in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharm Ther 998:506-509.
22. Kamei M, Fujita T, Kanbe T, et al. (1986).The distribution and content of ubiquinone in foods. Int J Vit Nutr Res 56:57-63.
23. Kaufman RH, Adam E, Vonka V (2000). Human papillomavirus infection and cervical carcinoma. Clin Obstet Gynecol 43:363-380.
24. 10. Biochem Biophys Res Commun 199:1504-1508.
25. Mackerras D, Irwig L, Simpson JM, et al. (1999). Randomized double-blind trial of β-carotene and vitamin C in women with minor cervical abnormalities. Br J Cancer 79:1448-1453.
26. Mayne ST (1996). β-Carotene, carotenoids, and disease prevention in humans. FASEB J 10:690-701.
27. Munoz N, Bosch FX, Sanjose S, et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
28. Nasiell K, Nasiell M, Vaclavinkova V (1983). Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 61:609-614.
29. Nasiell K, Roger V, Nasiell M (1986). Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 67:665-669.
30. Overvad K, Diamant B, Holm L, et al. (1999). Coenzyme Q10 in health and disease. Eur J Clin Nutr 53:764-770.
31. Palan PR, Mikhail MS, Goldberg GL et al. (1996). Plasma levels of β-carotene, lycopene, canthaxanthin, retinol, α-tocopherol and γ-tocopherol in cervical intraepithelial neoplasia. Clin Cancer Res 2:181-185.
32. Palan PR, Cheg CJ, Mikhail MS, et al. (1998). Plasma concentrations of micronutrients during a nine-month clinical trial of β-carotene in women with precursor cervical cancer lesions. Nutr Cancer 30:46-52.
33. Potischman N, Brinton LA (1996). Nutrition and cervical neoplasia. Cancer Causes Control 7:113-126.
34. Romney SL, Ho GY, Palan PR, et al. (1997). Effects of β-carotene and other factors on outcomes of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 65:484-492.
35. Schiffman MH, Castle P (2003). Epidemiologic studies of a necessary causal risk factor: Human papillomavirus infection and cervical cancer. J Natl Cancer Inst 95:E2.
36. Schlecht NF, Kulaga S, Robitaille J, et al. (2001). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286:3106-3114.
37. Stocker R, Bowry VW, Frei B (1991). Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 881:1646-1650.
38. Stoyanovsky DA, Osipov AN, Quinn PJ, Kagan VE (1995). Ubiquinone-dependent recycling of vitamin E radicals by superoxide. Arch Biochem Biophys 323:343-351.
39. Wallace DC (1999). Mitochondrial diseases in man and mouse. Science 283:1482-1488.
40. 10 in human blood plasma. Int J Vit Res 64:311-315.
41. 10 in the diet-daily intake and relative bioavailability. Mol Aspect Med 18:s251-s254.
42. 10 content of the average Danish diet. Int J Vit Nutr Res 67:123-129.